IndicationsAmbrisentan is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1):To improve exercise ability and delay clinical worsening.In combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to impro..